Speaker illustration

Doctor Kyle Lehenbauer

Columbia University Medical Center, New York (United States of America)

Impact of changes in tricuspid regurgitation on clinical outcomes following mitral valve teer compared to guideline-directed medical therapy: a sub-analysis of the COAPT trial

Event: EuroEcho 2021

Topic: Valvular Heart Disease

Session: New insights into the challenging tricuspid valve


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb